CSIMarket Company Name, Ticker, Customers, else..
 
Immunoprecise Antibodies Ltd   (NASDAQ: IPA)
 

IPA's Market share relative to its competitors, as of Q4 2024

As of Q4 2024 (Revenue in Millions of $)

Date modified: 2026-05-18T02:21:34+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months
Q4 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE
A Quarter Before
Q3 2024
Immunoprecise Antibodies Ltd 18.78 0.01% 0.01 % 0.00 %
Amgen Inc 45,369.00 33.62% 27.18% 45.06%
Thermo Fisher Scientific Inc 44,556.00 33.01% 37.83% 27.53%
Teva Pharmaceutical Industries Limited 17,350.00 12.86% 13.06% 9.96%
Viatris Inc 14,562.60 10.79% 11.85% 8.80%
Catalent Inc 4,422.00 3.28% 3.23% 3.25%
15 more competitors available

Sign in to see all competitors for Immunoprecise Antibodies Ltd .

Sign In Create Free Account



IPA's Market share relative to its competitors, as of Q4 2024 within the Major Pharmaceutical Preparations Industry
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Immunoprecise Antibodies Ltd 0.05% 0.04% 0.05 % 0.04 %
Teva Pharmaceutical Industries Limited 45.16% 45.46% 43.88% 42.49%
Viatris Inc 37.90% 37.66% 39.80% 37.52%
Catalent Inc 11.51% 11.54% 10.84% 13.88%
Evotec Se 2.30% 2.35% 2.30% 2.35%
Myovant Sciences Ltd 0.99% 0.88% 1.06% 1.12%
11 more companies available

Sign in to see all industry competitors for Immunoprecise Antibodies Ltd .

Sign In Create Free Account



IPA's Market share relative to its competitors, as of Q4 2024 within the Healthcare Sector
As of Q4 2024



COMPANY NAME MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
12 Months Ending
Q3 2024		 MARKET SHARE
MRQ
Q4 2024		 MARKET SHARE

Q3 2024
Immunoprecise Antibodies Ltd 0.02% 0.02% 0.02 % 0.02 %
Amgen Inc 50.18% 42.86% 43.72% 62.17%
Teva Pharmaceutical Industries Limited 19.19% 22.13% 21.01% 13.75%
Viatris Inc 16.11% 18.34% 19.06% 12.14%
Catalent Inc 4.89% 5.62% 5.19% 4.49%
Charles River Laboratories International inc 4.45% 5.15% 5.09% 3.44%
14 more companies available

Sign in to see all sector competitors for Immunoprecise Antibodies Ltd .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Immunoprecise Antibodies Ltd's market divisions, geographic dispersion, segments, products, and services, visit Immunoprecise Antibodies Ltd's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.